1. Home
  2. JMSB vs AGEN Comparison

JMSB vs AGEN Comparison

Compare JMSB & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Marshall Bancorp Inc.

JMSB

John Marshall Bancorp Inc.

HOLD

Current Price

$23.32

Market Cap

308.2M

Sector

Finance

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$6.96

Market Cap

274.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMSB
AGEN
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.2M
274.8M
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
JMSB
AGEN
Price
$23.32
$6.96
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$23.00
$14.50
AVG Volume (30 Days)
30.1K
8.2M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
1.72%
N/A
EPS Growth
24.17
100.00
EPS
0.93
1.02
Revenue
N/A
$42,877,086.00
Revenue This Year
$17.09
$107.63
Revenue Next Year
$10.03
N/A
P/E Ratio
$54.30
$7.34
Revenue Growth
N/A
89.95
52 Week Low
$18.50
$2.71
52 Week High
$24.26
$8.85

Technical Indicators

Market Signals
Indicator
JMSB
AGEN
Relative Strength Index (RSI) 59.22 66.62
Support Level $20.72 $3.09
Resistance Level N/A $8.70
Average True Range (ATR) 0.77 0.74
MACD 0.08 0.12
Stochastic Oscillator 65.15 65.22

Price Performance

Historical Comparison
JMSB
AGEN

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: